Posts by: Magdalena Kegel

Magdalena Kegel

Magdalena holds an MSc in Pharmaceutical Bioscience and an interdisciplinary PhD merging the fields of psychiatry, immunology and neuropharmacology. Her previous research focused on metabolic and immunologic changes in psychotic disorders. She is now focusing on science writing, allowing her to culture her passion for medical science and human health.

January 19, 2018January 19, 2018

Tumor Debris That’s Left After Treatment Can Reignite Cancer, Study Reports

News

Most cancer treatments create the perfect environment for the diseases to rejuvenate, researchers discovered in a study that could explain how tumors become resistant to chemotherapy. The tumor debris left ... Read more

December 22, 2017December 22, 2017

Blood Test Performs as Well as Tissue Biopsy in Characterizing Prostate Cancer, Study Finds

News

A blood test may one day replace tumor tissue sampling for patients with prostate cancer, as research shows that nearly 90 percent of a tumor’s genetic features can be detected ... Read more

December 20, 2017

Gel Based on Horse Chestnut Seen to Improve Cancer Imaging

News

A gel, made from a horse chestnut extract, may improve the imaging of tumors, including prostate cancer, using radioactive tracer molecules. A research team now hopes that, using the gel, ... Read more

December 7, 2017

Safety Concerns Make Bayer Unblind Prostate Cancer Trial of Xofigo Combination

News

An Independent Data Monitoring Committee has asked Bayer to unblind a Phase 3 clinical trial of a Xofigo (radium-223)-based therapy for prostate cancer after data indicated more bone fractures in ... Read more

October 16, 2017October 16, 2017

Precision Lymph Node Radiotherapy Could Improve Prostate Cancer Outcomes, Study Suggests

News

A highly precise type of radiotherapy called intensity-modulated radiation therapy (IMRT) may be a safer form of treating lymph nodes in patients with prostate cancer, a clinical trial report suggests. ... Read more

October 6, 2017

Poseida’s CAR T-cell Therapy Eradicates Previously Incurable Prostate Cancer in Mice

News

Poseida Therapeutics’ CAR T-cell therapy P-PSMA-101 eradicated a previously incurable type of human prostate cancer implanted in mice, the company reported. Another CAR T-cell therapy that has reached doctor’s offices ... Read more

October 5, 2017

Endocyte Pursuing Phase 3 Trial of 177Lu-PSMA-617 in Metastatic PC

News

Endocyte announced it will move PSMA-617 quickly into Phase 3 development in prostate cancer after it licensed the compound from German ABX. The trial, for which the company has yet ... Read more

September 25, 2017September 25, 2017

Inovio Advances New DNA-Based Antibody As Potential Therapy for Prostate Cancer

News

Inovio Pharmaceuticals reported that its experimental gene therapy-based antibody against prostate cancer has shown promising effects in early mouse studies of the approach, which combines advanced methods to combat cancer. ... Read more

September 13, 2017

Hormone Depletion Activates Tumor Survival Process in Prostate Cancer, Study Shows

News

Prostate cancer hormone depletion treatments might, in fact, be boosting cancer growth and making a tumor more aggressive, researchers at England’s University of Surrey found. Their study, which appeared in the journal ... Read more

September 12, 2017September 12, 2017

Two High-Risk Prostate Cancer Treatments Have Similar Benefits, Add-On Study Finds

News

Two treatment approaches — Zytiga (abiraterone acetate) plus prednisolone (AAP) or Taxotere (docetaxel) — provided patients with high-risk prostate cancer similar benefits when added to standard hormone deprivation therapy, according ... Read more